Literature DB >> 23438053

Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here?

Mirela Habibović1, Matthew M Burg, Susanne S Pedersen.   

Abstract

BACKGROUND: The implantable cardioverter defibrillator (ICD) is the first-line treatment for primary and secondary prevention of sudden cardiac death. A subgroup of patients experience psychological distress postimplant, and no clear evidence base exists regarding how best to address patients' needs. The aim of this critical review is to provide an overview of behavioral interventions in ICD patients to date, and to delineate directions for future research using lessons learned from the ongoing RISTA and WEBCARE trials.
METHODS: We searched the PubMed and PsycInfo databases to identify reports of behavioral trials targeting distress and related factors in ICD patients published between 1980 and April 2012.
RESULTS: We identified 17 trials for the review. Generally, compared to usual care, behavioral interventions were associated with reduced anxiety and depression and improved physical functioning, with effect sizes ranging from small to moderate-large (0.10-1.79 for anxiety; 0.23-1.20 for depression). Important limitations were small sample sizes and potential selection bias, hampering generalizability of the results. In addition to a need for larger trials, experiences from the RISTA and WEBCARE trials suggest that intervention trials tailored to the individual patient may be the way forward.
CONCLUSIONS: Behavioral interventions show promise with respect to reducing distress in ICD patients. Large-scale intervention trials targeted to the individual needs and preferences of patients are warranted, as a "one size fits all" approach is unlikely to work for all ICD patients. ©2013, The Authors. Journal compilation ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23438053      PMCID: PMC3809759          DOI: 10.1111/pace.12108

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  58 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D Altman
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

Review 2.  Quality of life and psychological functioning of icd patients.

Authors:  Samuel F Sears; Jamie B Conti
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

3.  Pre-implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation.

Authors:  Susanne S Pedersen; Madelein T Hoogwegt; Luc Jordaens; Dominic A M J Theuns
Journal:  Int J Cardiol       Date:  2011-11-08       Impact factor: 4.164

4.  Improving primary care for depression in late life: the design of a multicenter randomized trial.

Authors:  J Unützer; W Katon; J W Williams; C M Callahan; L Harpole; E M Hunkeler; M Hoffing; P Arean; M T Hegel; M Schoenbaum; S M Oishi; C A Langston
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

5.  Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men.

Authors:  James A Blumenthal; Michael Babyak; Jiang Wei; Christopher O'Connor; Robert Waugh; Eric Eisenstein; Daniel Mark; Andrew Sherwood; Pamela S Woodley; Richard J Irwin; Geoffrey Reed
Journal:  Am J Cardiol       Date:  2002-01-15       Impact factor: 2.778

6.  The effect of psychological intervention on patients' long-term adjustment to the ICD: a prospective study.

Authors:  C S Kohn; R J Petrucci; C Baessler; D M Soto; C Movsowitz
Journal:  Pacing Clin Electrophysiol       Date:  2000-04       Impact factor: 1.976

7.  Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design.

Authors: 
Journal:  Psychosom Med       Date:  2001 Sep-Oct       Impact factor: 4.312

8.  The role of the nurse in enhancing quality of life in patients with an implantable cardioverter-defibrillator: the Swedish experience.

Authors:  Eva Carlsson; S Bertil Olsson; Eva Hertervig
Journal:  Prog Cardiovasc Nurs       Date:  2002

Review 9.  Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

Authors:  Justin A Ezekowitz; Paul W Armstrong; Finlay A McAlister
Journal:  Ann Intern Med       Date:  2003-03-18       Impact factor: 25.391

10.  Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.

Authors:  A Fitchet; P J Doherty; C Bundy; W Bell; A P Fitzpatrick; C J Garratt
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

View more
  9 in total

1.  Preliminary Development of an Informational Media Use Measure for Patients with Implanted Defibrillators: Toward a Model of Social-Ecological Assessment of Patient Education and Support.

Authors:  Christopher E Knoepke; Daniel D Matlock
Journal:  Health Soc Work       Date:  2017-11-01

2.  Depression and Associated Factors in Patients with Implantable Cardioverter-Defibrillators.

Authors:  Maryam Moshkani Farahani; Mehrdad Taghipour; Mohsen Motalebi; Ramezan Bakhshian; Ehsan Shahverdi; Sovaid Taghipour; Soheyla Abdi; Ramzan Moradi
Journal:  J Tehran Heart Cent       Date:  2016-10-03

3.  A Personalized and Interactive Web-Based Health Care Innovation to Advance the Quality of Life and Care of Patients With Heart Failure (ACQUIRE-HF): A Mixed Methods Feasibility Study.

Authors:  Susanne S Pedersen; Thomas Schmidt; Søren Jensen Skovbakke; Uffe Kock Wiil; Kenneth Egstrup; Kim G Smolderen; John A Spertus
Journal:  JMIR Res Protoc       Date:  2017-05-23

4.  Enhancing Lifestyle Change in Cardiac Patients Through the Do CHANGE System ("Do Cardiac Health: Advanced New Generation Ecosystem"): Randomized Controlled Trial Protocol.

Authors:  Mirela Habibović; Eva Broers; Jordi Piera-Jimenez; Mart Wetzels; Idowu Ayoola; Johan Denollet; Jos Widdershoven
Journal:  JMIR Res Protoc       Date:  2018-02-08

5.  Attrition and adherence in a WEB-Based Distress Management Program for Implantable Cardioverter defibrillator Patients (WEBCARE): randomized controlled trial.

Authors:  Mirela Habibović; Pim Cuijpers; Marco Alings; Pepijn van der Voort; Dominic Theuns; Leon Bouwels; Jean-Paul Herrman; Suzanne Valk; Susanne Pedersen
Journal:  J Med Internet Res       Date:  2014-02-28       Impact factor: 5.428

6.  Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator.

Authors:  Anita Rahmawati; Akiko Chishaki; Tomoko Ohkusa; Hiroyuki Sawatari; Miyuki Tsuchihashi-Makaya; Yuko Ohtsuka; Mori Nakai; Mami Miyazono; Nobuko Hashiguchi; Harumizu Sakurada; Masao Takemoto; Yasushi Mukai; Shujirou Inoue; Kenji Sunagawa; Hiroaki Chishaki
Journal:  J Arrhythm       Date:  2015-11-19

7.  Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays.

Authors:  H Versteeg; J Denollet; M Meine; S S Pedersen
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

8.  Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.

Authors:  Susanne S Pedersen; Søren J Skovbakke; Uffe K Wiil; Thomas Schmidt; Rene dePont Christensen; Carl J Brandt; Jan Sørensen; Michael Vinther; Charlotte E Larroudé; Thomas M Melchior; Sam Riahi; Kim G E Smolderen; John A Spertus; Jens B Johansen; Jens C Nielsen
Journal:  BMC Cardiovasc Disord       Date:  2018-07-03       Impact factor: 2.298

9.  A smartphone app for sedentary behaviour change in cardiac rehabilitation and the effect on hospital admissions: the ToDo-CR randomised controlled trial study protocol.

Authors:  Kacie Patterson; Rachel Davey; Richard Keegan; Theophile Niyonsenga; Itismita Mohanty; Sander van Berlo; Nicole Freene
Journal:  BMJ Open       Date:  2020-12-15       Impact factor: 3.006

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.